C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
05/2011
05/24/2011	CA2490239C Substituted 2,4-dihydro-pyrrolo (3, 4-b) -quinolin-9-one derivatives useful as phosphodiesterase inhibitors
05/24/2011	CA2441235C Aryl and biaryl compounds having mch modulatory activity
05/24/2011	CA2393710C Caspase inhibitors and uses thereof
05/24/2011	CA2384378C Heterocyclic compounds useful as inhibitors of tyrosine kinases
05/24/2011	CA2342064C Long wave length absorbing bacteriochlorin alkyl ether analogs
05/19/2011	WO2011060216A1 Substituted azaindoles
05/19/2011	WO2011059887A1 Hepatitis c virus inhibitors
05/19/2011	WO2011059839A1 Bicyclic pyridines and analogs as sirtuin modulators
05/19/2011	WO2011059388A1 Oxazolo[4,5-c]pyridine substituted pyrazine
05/19/2011	WO2011059000A1 Compound having a substituted anthracene ring structure and pyridoindole ring structure, and organic electroluminescent element
05/19/2011	WO2011058766A1 Aryl carboxamide derivatives as ttx-s blockers
05/19/2011	WO2011058498A2 Method for increasing the solubility of a transcriptase inhibitor composition
05/19/2011	WO2011058474A1 N1-pyrazolospiroketone acetyl-coa carboxylase inhibitors
05/19/2011	WO2011058473A1 N2-pyrazolospiroketone acetyl-coa carboxylase inhibitors
05/19/2011	WO2011058193A1 [1,5]-diazocin derivatives
05/19/2011	WO2011058139A1 A compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent
05/19/2011	WO2011058036A1 Tricyclic compounds having herbicidal action
05/19/2011	WO2011058002A1 Labelled pyrrolyl-oxadiazolyl-diazabicyclononane derivatives and their use in diagnostic methods
05/19/2011	WO2011057989A1 Heterocyclic compounds having herbicidal action
05/19/2011	WO2011057974A1 Propane-i-sulfonic acid {3-[5-(4-chloro-phenyl)-1h-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide compositions and uses thereof
05/19/2011	WO2011057973A1 Oxazoline derivatives for treatment of cns disorders
05/19/2011	WO2011057942A1 Insecticidal methods using pyridine compounds
05/19/2011	WO2011057757A1 New 7-phenyl-[1,2,4]triazolo[4,3-a]pyridin-3(2h)-one derivatives
05/19/2011	WO2011057706A2 Materials for electronic devices
05/19/2011	WO2011017342A3 Mesoionic pesticides
05/19/2011	WO2011005731A3 Process for making cgrp receptor antagonist
05/19/2011	WO2010151740A4 Polycyclic derivatives of pyridine and their use in the treatment of (inter alia) rheumatoid arthritis and similar diseases
05/19/2011	WO2010111634A3 Renin inhibitors
05/19/2011	US20110118470 Nitrogen-containing aromatic derivatives
05/19/2011	US20110118303 Novel compounds derived from taurine, process of their preparation and pharmaceutical compositions containing these
05/19/2011	US20110118299 Treatment of mci and alzheimer's disease
05/19/2011	US20110118296 Bis-Carbazole DNA Intercalating Agents for Antitumor Therapy
05/19/2011	US20110118287 Bicycloheteroaryl Compounds As P2X7 Modulators and Uses Thereof
05/19/2011	US20110118279 Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives with protease inhibitors
05/19/2011	US20110118250 Beta-secretase modulators and methods of use
05/19/2011	US20110118249 Inhibitors of human immunodeficiency virus replication
05/19/2011	US20110118248 Heteroaryl sulfonamides and CCR2/CCR9
05/19/2011	US20110118246 Novel Compounds
05/19/2011	US20110118241 6-Pyridin-3-YL-3,4-Dihydro-1H-Quinolin-2-One Derivatives and Related Compounds as Inhibitors of the Human Aldosterone Synthase CYP11B2
05/19/2011	US20110118236 Heterocyclic compound
05/19/2011	US20110118230 Diazacarbazoles and methods of use
05/19/2011	US20110118199 Use of cns penetrating anticancer compounds for the treatment of protozoal diseases
05/19/2011	CA2781056A1 Kinase inhibitors
05/19/2011	CA2781014A1 Method for increasing the solubility of a transcriptase inhibitor composition
05/19/2011	CA2780812A1 Hepatitis c virus inhibitors
05/19/2011	CA2780568A1 Oxazoline derivatives for treatment of cns disorders
05/19/2011	CA2780031A1 A compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent
05/19/2011	CA2779303A1 Bicyclic pyridines and analogs as sirtuin modulators
05/19/2011	CA2779088A1 [1,5]-diazocin derivatives
05/19/2011	CA2778886A1 N1-pyrazolospiroketone acetyl-coa carboxylase inhibitors
05/19/2011	CA2778693A1 Propane-i-sulfonic acid {3-[5-(4-chloro-phenyl)-1h-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide compositions and uses thereof
05/19/2011	CA2778316A1 N-2 pyrazolospiroketone acetyl-coa carboxylase inhibitors
05/18/2011	EP2322628A2 Mutations in the BCR-ABL tyrosine kinase associated with resistance to STI-571
05/18/2011	EP2322627A2 Mutations in the BCR-abl tyrosine kinase associated with resistance to STI-571
05/18/2011	EP2322527A1 Triazole derivatives
05/18/2011	EP2322524A1 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings
05/18/2011	EP2322523A1 Pyridopyrimidinone Inhibitors of PI3Kalpha
05/18/2011	EP2322521A1 Heteroaryl compounds useful as inhibitors of GSK-3
05/18/2011	EP2322176A1 New 7-phenyl-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one derivatives
05/18/2011	EP2321320A1 Novel compounds and their uses in diagnosis
05/18/2011	EP2321319A1 Antiviral compounds
05/18/2011	EP2321318A1 Pyrazolopyridine kinase inhibitors
05/18/2011	EP2321317A1 Fused pyrrolidino-cyclopropane derivatives as selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
05/18/2011	EP2321316A1 Substituted pyrimidin-4-one derivatives
05/18/2011	EP2321315A2 Substituted alkyl pyrimidin-4-one derivatives
05/18/2011	EP2321314A2 Substituted pyrimidone derivatives
05/18/2011	EP2321313A1 Substituted pyrimido [2, 1-a]isoquinolin-4-one derivatives
05/18/2011	EP2321312A1 Process for the preparation of paliperidone
05/18/2011	EP2321311A1 Synthesis of paliperidone
05/18/2011	EP2321307A1 Tricyclic alkylaminomethyloxazolidinone derivatives
05/18/2011	EP2321303A2 Compounds that modulate intracellular calcium
05/18/2011	EP2321296A1 Substituted 5-aminopyrazoles and use thereof
05/18/2011	EP2320907A1 Therapeutic compounds
05/18/2011	EP2320906A1 Heterocyclic amide derivatives as ep4 receptor antagonists
05/18/2011	EP2320895A2 Cdk modulators
05/18/2011	EP2158194B1 Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics
05/18/2011	EP2129672B1 Azaadamantane ester and carbamate derivatives and methods of use thereof
05/18/2011	EP2086976B1 Method for producing pradofloxacin
05/18/2011	EP1581221B1 Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonists
05/18/2011	CN1977793B Composition comprising at least one cationic 3-amino-pyrazolopyridine derivative
05/18/2011	CN102066385A New peptidomimetic compounds
05/18/2011	CN102066374A Threefold and fourfold substituted pentarylene tetracarboxylic acid diimides
05/18/2011	CN102066373A Semiconductor materials and methods of preparation and use thereof
05/18/2011	CN102066372A 5,6-bicyclic heteroaryl-containing urea compounds as kinase inhibitors
05/18/2011	CN102066371A Aryl-quinolyl compounds and their use
05/18/2011	CN102066370A Novel phenyl-imidazopyridines and pyridazines
05/18/2011	CN102066359A Novel heteroaryl carboxamide derivatives
05/18/2011	CN102066358A CGRP receptor antagonists
05/18/2011	CN102066342A Quinoxalinedione derivatives
05/18/2011	CN102066338A Inhibitors of protein kinases
05/18/2011	CN102066322A Compound having NPY Y5 receptor antagonist activity
05/18/2011	CN102060857A Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
05/18/2011	CN102060856A Method for extracting tabersonine from voacanga seeds
05/18/2011	CN102060855A Method for preparing octahydro-pyrro-[3,4-c] pyridine-derivatives
05/18/2011	CN102060854A Nitrile substituted quinacridone compounds and application thereof in organic solar cell
05/18/2011	CN101585836B Novel method for preparing Nevirapine
05/18/2011	CN101328174B Method for preparing 3-(2-chloroethyl)-2-methyl-4H- naphthyridine[1,2-a]pyrimidine-4-ketone
05/17/2011	US7943770 Fused quinoline derivative and use thereof
05/17/2011	US7943645 Piperidine compounds for use as orexin receptor antagonist
05/17/2011	US7943639 Such as 6-benzenesulfonyl-4-piperazin-1-yl-quinoline hydrochloride; for treatment of central nervous system and/or 5- HT6 receptor related disorders; for weight gain/loss

1 ... 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 ... 646